Beckman Coulter Genomics has announced an accreditation from the College of American Pathologists (CAP). Its facility in Danvers completed a comprehensive on-site inspection as a part of the CAP's accreditation program. The CAP Laboratory Accreditation Program involves a process of inspections of clinical lab records and quality control procedures and assessments of a lab's staff qualifications, equipment, facilities, safety program, and overall management.

"Beckman Coulter Genomics is proud to achieve accreditation from the College of American Pathologists. CAP accreditation is recognized as the 'high-water mark' for laboratory testing. I congratulate the entire team at Beckman Coulter Genomics. This accomplishment underscores our commitment to advancing healthcare for every person and reinforces our determination to deliver the highest standards of excellence," said Mr Tim Anderson, vice president and general manager of genomic services, Beckman Coulter.

The accreditation strengthens the company's strong bioinformatics expertise and extensive experience in study design, guidance and analysis of customer's crucial clinical samples.

"CAP accreditation signifies that our lab operates under rigorous quality standards to generate highly accurate and reliable data. We are pleased to be able to provide our customers a sequencing service which satisfies the exacting requirements of regulatory authorities and will help the facility more quickly move findings from clinical trials into clinical use," said Dr Stephen Lyle, laboratory director at Beckman Coulter Genomics.